Skip to content

Use of Non Invasive Hemodynamic Cardiovascular Monitoring to Evaluate Emergency Department Patients

Assessments of Early Hemodynamics in Emergency Department Patients and Evaluation of Trends and Variability in Prediction of Life-saving Interventions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00851214
Enrollment
40
Registered
2009-02-25
Start date
2009-03-31
Completion date
2009-06-30
Last updated
2010-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure, COPD, Sepsis, Stroke, Trauma

Keywords

Non-invasive hemodynamic monitoring, Emergency Department patients, trauma with an ISS>15, Non-invasive continuous hemodynamic monitoring

Brief summary

This study is an observational prospective pilot trial that utilizes finger cuff non invasive hemodynamic monitoring (NexfinHD Monitor) to assess 4 different groups (CHF/COPD, Trauma, Sepsis, Stroke) of patients on arrival to the Emergency Department and to document the changes seen in these hemodynamics with acute therapies.

Detailed description

There has been little very early (after Emergency Department presentation) hemodynamic monitoring of acutely ill or injured patients secondary to the lack of non invasive technologies that could be reliably applied to this patient population.Thus all assessments of hemodynamics have been made by physicians on clinical information including intermittent pulse and blood pressure measurements. It is not known what the underlying continuous cardiac output, systemic vascular resistance, etc are in these patients and how these change with current Emergency Medicine therapeutic interventions. Currently there is available a finger cuff devise (NexfinHD Monitor, BMEYE, Amsterdam) that can measure these hemodynamics on a beat to beat basis and that can be easily applied to acutely ill individuals. This prospective pilot study of 48 patients (4 groups of 12 each) will document the hemodynamics of patients on arrival and continuously for 2 hours, blinded to the treating physician. Treating physicians will be asked to estimate these hemodynamic parameters at various time points. The study will characterize the hemodynamics of patients, compare them to the estimates of treating physicians and determine whether they predict the need for life saving interventions.

Interventions

DEVICENexfinHD Monitor

Finger cuff device (NexfinHD Monitor, BMEYE, Amsterdam) that can measure hemodynamics on a beat to beat basis and that can be easily applied to acutely ill individuals.

Sponsors

BMEYE, Amsterdam The Netherlands
CollaboratorUNKNOWN
Henry Ford Health System
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with acute CHF/COPD (n=12) * Patients with acute trauma and a trauma ISS\>15 (n=12) * Patients with acute sepsis (n=12) * Patients with acute stroke (n=12)

Exclusion criteria

* Patients in cardiopulmonary arrest * patients with STEMI * Patients with known peripheral vascular disease * Pregnant patients * Age\<18 * Excessively agitated patients * Interference with current standard of acre

Design outcomes

Primary

MeasureTime frame
To elucidate the hemodynamics of the cohort of four different groups of patients in the early hours of their presentationEmergency Department (ED) arrival to 2 hours

Secondary

MeasureTime frame
Comparison of clinical estimation of hemodynamics and values estimated by the NexfinHD on arrival and for up to 6 hoursED arrival to 6 hours
To compare if abnormal hemodynamics as measured by the NexfinHD and clinical assessment after arrival to the ED in the 4 groups predicts life saving interventions within 2 hoursED arrival to 2 hours
To calculate short term hemodynamic variability parameters and their prediction of life saving interventions within 2 hours and subjective/objective estimation of clinical improvementED arrival to 2 hours
Estimation of bias and precision of the non invasive hemodynamic trends in unselected patient group by assessing the validity of measurements with invasive measurements if usedED arrival to 2 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026